Alteogen

Alteogen ROA

The Return on Assets (ROA) of Alteogen (196170.KQ) as of Nov 4, 2026 is 20.27 %. In the previous year, Return on Assets (ROA) was 15.22 % — a change of 33.21% (higher).

ROA

20.27 %

YoY

33.21%

Last updated:

In 2025, Alteogen's return on assets (ROA) was 20.27 %, a 33.21% increase from the 15.22 % ROA in the previous year.

The Alteogen ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
-9.63 KRW
Jan 1, 2019
-0.82 KRW
Jan 1, 2020
-0.61 KRW
Jan 1, 2021
2.31 KRW
Jan 1, 2022
-3.32 KRW
Jan 1, 2023
-1.32 KRW
Jan 1, 2024
15.22 KRW
Jan 1, 2025
20.27 KRW
The Alteogen ROA history
YEARROAYoY
20.27 %+33.21%
15.22 %-1,256.04%
-1.32 %-60.32%
-3.32 %-243.95%
2.31 %-478.49%
-0.61 %-25.68%
-0.82 %-91.49%
-9.63 %-44.41%
-17.32 %+131.48%
-7.48 %-343.84%
3.07 %+25.07%
2.45 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alteogen Stock analysis

What does Alteogen do? Alteogen, Inc. generates revenue through its biobetter business segment, developing protein pharmaceuticals and cancer therapies, and its bio similar business segment, focusing on bio similar and animal medicines. The company sells growth hormone, herceptin, humira, antibodies, and other products primarily to healthcare providers and pharmaceutical distributors. Its biobetter segment targets oncology and protein-based treatments, while the bio similar segment serves both human and animal health markets with cost-effective alternatives to branded drugs. The firm's product portfolio includes growth hormone, herceptin, and humira, which are key revenue drivers in the biopharmaceutical sector. Herceptin and humira are well-established anticancer drugs, while growth hormone addresses endocrine disorders. The company's bio similar segment offers affordable versions of these therapies, appealing to budget-conscious healthcare systems and veterinary markets. Sales are concentrated in the human and animal medicine sectors, leveraging its dual focus on biobetter and bio similar products. Alteogen is one of the most popular companies on Eulerpool.

ROA Details

Understanding Alteogen's Return on Assets (ROA)

Alteogen's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Alteogen's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Alteogen's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Alteogen’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Alteogen stock

Return on Assets (ROA) of Alteogen is 20.27 % in 2025.

Return on Assets (ROA) of Alteogen changed from 15.22 % to 20.27 %, representing a 33.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Alteogen since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Alteogen with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Alteogen

All Key Metrics — Alteogen